Guo Li-Hua, Hu Ke-Feng, Miao Min, Ding Yong, Zhang Xin-Jun, Ye Guo-Liang
Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo 315020, Zhejiang Province, China.
World J Gastrointest Endosc. 2025 Jun 16;17(6):106412. doi: 10.4253/wjge.v17.i6.106412.
BACKGROUND: Colorectal laterally spreading tumors (LSTs) are best treated with endoscopic submucosal dissection or endoscopic mucosal resection. AIM: To analyze the clinicopathological and endoscopic profiles of colorectal LSTs, determine predictive factors for high-grade dysplasia (HGD)/carcinoma (CA), submucosal invasion, and complications. METHODS: We retrospectively assessed the endoscopic and histological characteristics of 375 colorectal LSTs at our hospital between January 2016 and December 2023. We performed univariate and multivariate analysis to identify risk factors associated with HGD/CA, submucosal invasion and complications. RESULTS: The numbers of granular (LST-G) and non-granular LST (LST-NG) were 260 and 115, respectively. The rates of low-grade dysplasia and HGD/CA were 60.3% and 39.7%, respectively. Multivariate analysis indicated that a tumor size ≥ 30 mm [odds ratio (OR) = 1.934, = 0.032], LST granular nodular mixed type (OR = 2.100, = 0.005), and LST non-granular pseudo depressed type (NG-PD) (OR = 3.016, = 0.015) were independent risk factors significantly associated with higher odds of HGD/CA. NG-PD (OR = 6.506, = 0.001), tumor size (20-29 mm) (OR = 2.631, = 0.036) and tumor size ≥ 30 mm (OR = 3.449, = 0.016) were associated with increased odds of submucosal invasion. Tumor size ≥ 30 mm (OR = 4.888, = 0.003) was a particularly important predictor of complications. A nomogram model demonstrated a satisfactory fit, with an area under the receiver operating characteristic curve of 0.716 (95% confidence interval: 0.653-0.780), indicating strong predictive performance. CONCLUSION: The novel nomogram incorporating tumor size, location, and morphology predicted HGD/CA during endoscopic resection for LSTs. NG-PD lesions larger than 20 mm were more likely to invade the submucosa. Tumor size ≥ 30 mm was an important predictor of complications.
背景:结直肠侧向发育型肿瘤(LSTs)最好采用内镜黏膜下剥离术或内镜黏膜切除术治疗。 目的:分析结直肠LSTs的临床病理和内镜特征,确定高级别异型增生(HGD)/癌(CA)、黏膜下层浸润及并发症的预测因素。 方法:我们回顾性评估了2016年1月至2023年12月间我院375例结直肠LSTs的内镜及组织学特征。我们进行了单因素和多因素分析,以确定与HGD/CA、黏膜下层浸润及并发症相关的危险因素。 结果:颗粒型(LST-G)和非颗粒型LST(LST-NG)的数量分别为260例和115例。低级别异型增生和HGD/CA的发生率分别为60.3%和39.7%。多因素分析表明,肿瘤大小≥30 mm [比值比(OR)=1.934,P = 0.032]、LST颗粒结节混合型(OR = 2.100,P = 0.005)和LST非颗粒假凹陷型(NG-PD)(OR = 3.016,P = 0.015)是与HGD/CA发生几率显著相关的独立危险因素。NG-PD(OR = 6.506,P = 0.001)、肿瘤大小(20 - 29 mm)(OR = 2.631,P = 0.036)和肿瘤大小≥30 mm(OR = 3.449,P = 0.016)与黏膜下层浸润几率增加相关。肿瘤大小≥30 mm(OR = 4.888,P = 0.003)是并发症的一个特别重要的预测因素。列线图模型显示拟合良好,受试者操作特征曲线下面积为0.716(95%置信区间:0.653 - 0.780),表明预测性能良好。 结论:纳入肿瘤大小、位置和形态的新型列线图可预测LSTs内镜切除术中的HGD/CA。直径大于20 mm的NG-PD病变更易侵犯黏膜下层。肿瘤大小≥30 mm是并发症的重要预测因素。
World J Gastrointest Endosc. 2025-6-16
Can J Gastroenterol Hepatol. 2025-6-11
World J Gastrointest Oncol. 2022-7-15
Cochrane Database Syst Rev. 2022-6-6
Cochrane Database Syst Rev. 2017-11-2
Cochrane Database Syst Rev. 2017-12-22
World J Gastrointest Oncol. 2022-7-15